The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
ALX Oncology (ALX) is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway. Our lead candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents. For more information about us, please visit www.alxoncology.com.
We are looking for an exceptionally talented and motivated individual to join our team as Senior Director, Regulatory Affairs. This position will be responsible for developing and executing innovative regulatory strategies in support of the global development program for ALX148. In this hands-on role, the individual will provide dynamic leadership and direction to multi-disciplined project teams and will work collaboratively with cross-functional team members to achieve development milestones in an efficient and compliant manner. This position will also support and provide key contributions to department and company initiatives related to regulatory affairs operations and strategy.
These include but are not limited to:
Providing dynamic regulatory leadership and guidance to project teams and working collaboratively with cross-functional team members, external contractors, vendors and consultants to identify optimum and effective regulatory strategies for assigned projects.
Lead teams in examining regulatory strategy options, provide relevant regulatory guidance / precedents and stay abreast of the regulatory and competitive landscape.
Identify and assess regulatory risks associated with development programs and define strategies to mitigate risks.
Monitor and analyze regulatory agency activities in areas of interest to the company and assess potential impact on development programs. Take a global view of regulatory strategy and help teams navigate regional requirements and the potential interplay between key regulatory agencies.
Prepare and lead teams through successful regulatory meetings and interactions.
Lead the authoring, review and editing of high-quality, compliant regulatory documents according to specified timelines and goals.
Lead assigned department initiatives and seek opportunities to improve interdepartmental collaboration.
Build positive professional relationships and trust with team mates, collegues and regulatory authority contacts.
Assist in organization and management of staff in the RA group, including coaching, career development and oversight of work.
ALX Oncology is an equal opportunity employer. All applicants should be legally entitled to work for any employer in the US. Title and salary are commensurate with experience. Our compensation program includes competitive salary, equity participation and attractive bonus incentives.
To apply for this position, please send your cover letter and resume to email@example.com
Bachelors degree; advanced degree desirable.
10+ years Regulatory Affairs experience in the biopharmaceutical industry or equivalent.
Extensive knowledge of regulatory requirements and early to late-stage experience with US, EU, RoW regulatory submissions for therapeutic products and IVDs (IDE/IND/CTA/510K/PMA/BLA /NDA, etc) in eCTD format.
Ability to develop, understand and implement complex development strategies in the field of oncology.
Demonstrated successful track record of interacting with regulatory health authorities and effectively moving products through the development process.
As a member of interdisciplinary teams, ability to successfully manage multiple project deliverables, with ability to function independently in management of critical biopharmaceutical programs.
Ability to create and manage detailed timelines and track regulatory activities across disciplines and territories.
Experience in Pediatric, Orphan Drug, Fast Track and Breakthrough Therapy, etc. development and understanding of US, EU and RoW regulations related to these regulatory pathways.
Prior experience in other key functional areas, (e.g., research, toxicology, pharmacology, chemistry/manufacturing, clinical research and/or biometrics).
Strong interpersonal skills and excellent oral / written communication skills.
Highly responsible, self-motivated professional.
Strong leadership skills that include a desire for accountability.
Highly collaborative working style with the ability to influence others.
Superior work ethic that includes working autonomously with an appropriate sense of urgency and accuracy.
Entrepreneurial orientation with the ability to effectively operate in a dynamic environment.
Ability to problem-solve on complex issues, often in a cross-functional team setting.
Prior experience managing direct reports, including coaching and career development.
Excellent organizational skills that enable the successful execution of multiple simultaneous projects.
High energy, enthusiasm and passion for the work.
This position may require periodic travel.
Telecommuting is allowed.
Internal Number: 01
About ALX Oncology Inc.
ALX Oncology (ALX) is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway. Our lead candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.